Prevalence and prognostic impact of aortic stenosis in wild-type transthyretin cardiac amyloidosis

17 May 2025 (10:00 - 10:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Hugo Malerbi

Toulouse Rangueil University Hospital of Toulouse, Toulouse (France)

4 More presentations in this session

Presentation thumbnail

Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: the role of overlap with arrhythmogenic cardiomyopathy

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

Towards a prognostically meaningful definition of non-dilated left ventricular cardiomyopathy

Doctor A. Aimo (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

Relation of reduced left ventricular global longitudinal strain with exercise pulmonary hypertension and clinical implication in rheumatic mitral stenosis

Doctor S. Lee (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Predictors of right ventricular dysfunction in patients with surgical repair of Tetralogy of Fallot - significance of biomarkers

Assistant Professor E. Begic (Sarajevo, BA)

Abstract Slides Video

Access the full session

Session thumbnail

Diagnosis and prognosis in cardiomyopathies and valvular disease

The Event

Event poster

Heart Failure 2025

17 May 2025 10:00 CET

You may be interested in

Congress Presentation

Prognostic significance of concomitant transthyretin cardiac amyloidosis and severe aortic stenosis: insights from a systematic review and meta-analysis

Congress Presentation

Impact, prognostic implications and treatment trends of aortic stenosis across the heart failure spectrum

Congress Presentation

Valvular heart disease in transthyretin cardiac amyloidosis

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources